stockrowFortrea Holdings Inc.
FTRE Healthcare Biotechnology
Fortrea Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 1.00% from fiscal 2024.
- Revenue
- −1.40%
- EPS
- +103.7%
- Free cash flow
- −34.0%
- Total debt
- −6.33%
Quarter to September 2026, against a year earlier
Follow FTRE
Alert me
Fortrea Holdings Inc. (FTRE) Return on invested capital
Fortrea Holdings Inc.'s return on invested capital over the twelve months to 30 September 2026 was 0.59%, up 38.4 percentage points from fiscal 2025 (−37.8%). Over the past ten years it has ranged from −37.8% (fiscal 2025) to 3.55% (fiscal 2022) — the current reading is the lowest in ten years. That is above the Biotechnology industry median of 0.00% and above the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | −37.8% | (33.56) |
| FY2024 | −4.27% | (4.90) |
| FY2023 | 0.63% | (2.92) |
| FY2022 | 3.55% | 3.55 |
| FY2021 | 0.00% | — |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| HRMY Harmony Biosciences Holdings, Inc. compare | 30.5% |
| FTRE Fortrea Holdings Inc. | 0.59% |
| ZYME Zymeworks Inc. compare | 0.00% |
| TRAX First Tracks Biotherapeutics, Inc. compare | 0.00% |
| SRPT Sarepta Therapeutics, Inc. compare | −2.03% |
| VIR Vir Biotechnology, Inc. compare | −30.3% |
| REPL Replimune Group, Inc. compare | −928.3% |
| IMNM Immunome, Inc. compare | −3,323.0% |
| BHVN Biohaven Ltd. compare | −6,659.9% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)